Schedule One Update - Chaleit Holdings plc
ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")
COMPANY NAME:
Chaleit Holdings plc (the "Company", "Chaleit" or, together with its subsidiaries, the "Group")
COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :
Botanic House
100 Hills Road
Cambridge
Cambridgeshire CB2 1PH
United Kingdom
COUNTRY OF INCORPORATION:
England and Wales
COMPANY WEBSITE ADDRESS (CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26):
chaleitplc.com
COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:
Chaleit is a penetration testing and offensive security consultancy, examining technology from the perspective of a malicious attacker to reveal how vulnerabilities arise, how systems can be compromised, and how organisations can respond before those vulnerabilities are exploited.
Chaleit has also built a broader consultancy encompassing AI and language model security, cloud security and development security operations engineering, and cyber advisory, governance and compliance work, applied individually or in combination according to its clients' needs. The Group also invests in extending its knowledge beyond individual client relationships. Experience gained through technical practice and continuing client engagement is complemented by structured research and engagement with senior cyber security practitioners and academia.
The Company's main country of operation is the United Kingdom.
DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):
Number of ordinary shares of 0.25 pence each in the capital of the Company ("Ordinary Shares") to be admitted: 22,470,298
Issue Price: 50 pence
No Ordinary Shares held in treasury
No restrictions on transfer of the Ordinary Shares
CAPITAL TO BE RAISED ON ADMISSION (AND/OR SECONDARY OFFERING) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:
Capital to be raised on admission: Approximately £2.1 million, of which £1.1 million will be satisfied by the issue of new Ordinary Shares and £1.0 million will be satisfied by the sale of existing Ordinary Shares, held by Daniel Stuart Haagman
Anticipated market capitalisation on admission: £11.2 million
PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:
81.96%
DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM SECURITIES (OR OTHER SECURITIES OF THE COMPANY) ARE OR WILL BE ADMITTED OR TRADED:
N/A
THE COMPANY HAS APPLIED FOR THE VOLUNTARY CARBON MARKET DESIGNATION (Y/N)
No
FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):
Professor Daniel ("Dan") Stuart Haagman - Chief Executive Officer
Mr Eric Kenelm ("Ken") Ford - Independent Non-Executive Chairman
Ms Jody Hyde - Chief Financial Officer and Chief Operating Officer
Mr Robert Naylor - Independent Non-Executive Director
FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):
Shareholding
Shareholder
Pre-admission
Post-admission
Daniel ("Dan") Stuart Haagman and close relatives
81.59%1
65.22%
Jody Hyde and close relatives
9.95%2
9.14%
Eric Kenelm ("Ken") Ford
6.47%3
5.82%
Richard Penny
-
5.12%
1Prior to admission, none of the close relatives of Dan Haagman held any interest in the Company.
2Prior to admission, none of the close relatives of Jody Hyde held any interest in the Company.
3Includes 1,006,360 Ordinary Shares owned by Mintonview Limited, a company controlled by Eric Kenelm Ford.
NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:
N/A
(i) ANTICIPATED ACCOUNTING REFERENCE DATE
(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)
(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:
i) 31 March
ii) 31 March 2026 (audited annual results)
iii) 31 December 2026 (unaudited interim results for the six months ending 30 September 2026)
30 September 2027 (audited annual results for the year ending 31 March 2027)
31 December 2027 (unaudited interim results for the six months ending 30 September 2027)
EXPECTED ADMISSION DATE:
7 October 2026
NAME AND ADDRESS OF NOMINATED ADVISER:
Strand Hanson Limited
26 Mount Row
London W1K 3SQ
United Kingdom
NAME AND ADDRESS OF BROKER:
Oberon Investments Limited (trading as Oberon Capital)
6 Duke Street St. James's
2nd Floor
London SW1Y 6BN
United Kingdom
OTHER THAN IN THE CASE OF AN EXPRESS APPLICANT THAT IS NOT REQUIRED TO PRODUCE AN ADMISSION DOCUMENT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:
The Admission Document, which will contain full details about the applicant and the admission of its securities, will be available on the Company's website at chaleitplc.com from the date of admission.
DATE OF NOTIFICATION:
2 October 2026
NEW/ UPDATE:
UPDATE
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDAIMBLLFBQBLXFBE
